Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Esophageal Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00678535
What this trial is testing

Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer

Who this might be right for
Gastric Cancer
Merck KGaA, Darmstadt, Germany 904
Testing effectiveness (Phase 2)UnknownNCT01267578
What this trial is testing

Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II)

Who this might be right for
Esophageal Cancer
University of Yamanashi 60
Early research (Phase 1)Looking for participantsNCT07519655
What this trial is testing

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

Who this might be right for
Non-Small-Cell LungEsophageal CancerCutaneous Melanoma
Pfizer 250
Early research (Phase 1)Study completedNCT00423254
What this trial is testing

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Who this might be right for
OvarianMelanomaRenal+20 more
Mannkind Corporation 12
Testing effectiveness (Phase 2)Looking for participantsNCT06410651
What this trial is testing

Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal CancerNimotuzumabChemoradiotherapy+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 53
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06965829
What this trial is testing

The Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for cT3N+ EC

Who this might be right for
Esophageal Cancer Stage III
Shanghai Chest Hospital 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06116136
What this trial is testing

Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers.

Who this might be right for
MSI-H/dMMR Gastroesophageal-junction CancerMSI-H/dMMR Gastric Cancer
Servier Bio-Innovation LLC 48
Large-scale testing (Phase 3)Study completedNCT02399306
What this trial is testing

Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaEnteral Nutrition TherapyChemoradiotherapy
Sichuan Cancer Hospital and Research Institute 222
Early research (Phase 1)Ended earlyNCT04594811
What this trial is testing

NT-I7 in Combination With Nivolumab in Advanced Gastric, Gastro-Esophageal Junction or Esophageal Adenocarcinoma

Who this might be right for
Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC)
NeoImmuneTech 10
Post-approval studies (Phase 4)Study completedNCT02721563
What this trial is testing

A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC

Who this might be right for
Esophageal Neoplasms
Shandong Cancer Hospital and Institute 77
Early research (Phase 1)Looking for participantsNCT07277413
What this trial is testing

IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Who this might be right for
NSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+10 more
IDEAYA Biosciences 260
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06814158
What this trial is testing

Neoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer

Who this might be right for
Esophageal Squamour Cell Cancer
Tianjin Medical University Cancer Institute and Hospital 57
Not applicableActive Not RecruitingNCT06762158
What this trial is testing

NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
RenJi Hospital 50
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Not applicableNot Yet RecruitingNCT04616040
What this trial is testing

A Real-world Study Evaluating the Usage of Camrelizumab in Chinese Patients With Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Peking University 1,030
Large-scale testing (Phase 3)Ended earlyNCT01704690
What this trial is testing

Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Peking University 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT03505320
What this trial is testing

Zolbetuximab (IMAB362) in Adults With Gastric Cancer

Who this might be right for
Pharmacokinetics of ZolbetuximabGastric CancerGastro-esophageal Junction (GEJ) Cancer+2 more
Astellas Pharma Global Development, Inc. 143
Early research (Phase 1)Study completedNCT00019435
What this trial is testing

LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+4 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT02489201
What this trial is testing

Donafenib Monotherapy in Advanced Oesophageal Cancer

Who this might be right for
Oesophageal Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 19
Not applicableNot Yet RecruitingNCT07533357
What this trial is testing

Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Fudan University 158
Next Page